Company successfully listed on Nasdaq under the symbol “AIFF”Partnered with multiple neuroscience pharmaceutical companies, including Bright ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

Novel scar-free robotic technology may define a new standard in minimally invasive surgery. EndoQuest's novel scar-free ...

At Neurogene, the developer of a gene therapy for Rett syndrome, expediency seems to be the priority, @adamfeuerstein writes.

Aldeyra received an FDA CRL for reproxalap, necessitating an additional study for DED approval. Read why I continue to rate ...